At Euronext Paris, the Abivax share gains significantly today. The share price of the biotech company is currently up around…
Read More »Abivax
The French biotech company Abivax is preparing for a possible commercialization of its drug candidate ABX464. “Further development of ABX464…
Read More »Abivax has agreed on loan financing totaling 15 million euros with the investor Kreos Personal-Financial.com. In addition, there is an…
Read More »
At Euronext Paris, more than 7 percent price gain is currently recorded for the Abivax share, which is quoted at…
Read More »
Abivax can extend a Phase IIb / III trial in Corona to Brazil. The authorities there have given the green…
Read More »
On the day on which CureVac receives 300 million euros from the German state through a capital increase, Abivax also…
Read More »